WSD0628: A BRAIN PENETRABLE ATM INHIBITOR AS A RADIOSENSITIZER FOR THE TREATMENT OF GBM AND METASTATIC CNS TUMOR

被引：0
|
作者：
Zhong, Wei [1 ]
Liu, Lily [1 ]
Sun, Claire [1 ]
Mu, Zhihua [1 ]
机构：
[1] Wayshine Biopharm, Corona, CA USA
来源：
NEURO-ONCOLOGY | 2021年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
DDRE-25
引用
收藏
页码：79 / 79
页数：1
相关论文
共 15 条
  • [1] PHARMACOKINETICS AND CNS DISTRIBUTION OF A NOVEL ATM INHIBITOR, WSD0628, FOR THE TREATMENT OF BRAIN TUMORS
    Rathi, Sneha
    Oh, Ju-Hee
    Sarkaria, Jann
    Elmquist, William F.
    NEURO-ONCOLOGY, 2022, 24 : 95 - 95
  • [2] Systemic and CNS distributional pharmacokinetics of WSD0628, a novel radiosensitizer: Implications for the treatment of brain tumors
    Rathi, Sneha
    Mladek, Ann
    Xue, Zhiyi
    Oh, Ju-Hee
    Zhang, Wenjuan
    Zhang, Wenqiu
    Le, Jiayan
    Sarkaria, Jann S.
    Elmquist, William F.
    CANCER RESEARCH, 2024, 84 (05)
  • [3] WSD0922: A BBB penetrable EGFR/EGFRVIII inhibitor for the treatment of GBM and metastatic CNS tumor
    Zhong, Wei
    Zhang, Jinqiang
    Mu, Ahihua
    Sun, Claire
    CANCER RESEARCH, 2019, 79 (13)
  • [4] Preclinical Systemic Pharmacokinetics, Dose Proportionality, and Central Nervous System Distribution of the ATM Inhibitor WSD0628, a Novel Radiosensitizer for the Treatment of Brain Tumors
    Rathi, Sneha
    Oh, Ju-Hee
    Zhang, Wenjuan
    Mladek, Ann C.
    Garcia, Darwin A.
    Xue, Zhiyi
    Burgenske, Danielle M.
    Zhang, Wenqiu
    Le, Jiayan
    Zhong, Wei
    Sarkaria, Jann N.
    Elmquist, William F.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2024, 390 (02): : 260 - 275
  • [5] Modeling the Acute Mucosal Toxicity of Fractionated Radiotherapy Combined with the ATM Inhibitor WSD0628
    Garcia, Darwin A.
    Rathi, Sneha
    Connors, Margaret A.
    Grams, Michael
    Vaubel, Rachael A.
    Bakken, Katrina K.
    Ott, Lauren L.
    Carlson, Brett L.
    Hu, Zeng
    Decker, Paul A.
    Eckel-Passow, Jeanette E.
    Burgenske, Danielle M.
    Zhong, Wei
    Trzasko, Joshua D.
    Herman, Michael G.
    Elmquist, William F.
    Remmes, Nicholas B.
    Sarkaria, Jann N.
    MOLECULAR CANCER THERAPEUTICS, 2025, 24 (02) : 299 - 309
  • [6] The radiosensitizing effects of the novel brain penetrant and potent ATM inhibitor WSD0628 in glioblastoma and melanoma patient derived xenografts
    Xue, Zhiyi
    Mladek, Ann C.
    Rathi, Sneha
    Burgenske, Danielle M.
    Gupta, Shiv K.
    Carlson, Brett L.
    Hu, Zeng
    Ott, Lauren L.
    Bakken, Katrina K.
    Vaubel, Rachael A.
    Elimquist, William F.
    Zhong, Wei
    Sarkaria, Jann N.
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [7] WSD0922: A BBB PENETRABLE EGFR/EGFRVIII SMALL MOLECULE FOR THE TREATMENT OF GBM AND METASTATIC CNS TUMOR
    Zhong, Wei
    Zhang, Jinqiang
    Mu, Zhihua
    Sun, Claire
    NEURO-ONCOLOGY, 2018, 20 : 73 - 73
  • [8] WSD-0628, a novel brain penetrant ATM inhibitor, radiosensitizes GBM and melanoma patient derived xenografts
    Tuma, Ann Mladek
    Zhong, Wei
    Liu, Lily
    Burgenske, Danielle M.
    Carlson, Brett L.
    Bakken, Katrina K.
    Hu, Zeng
    Connors, Margaret A.
    Sarkaria, Jann N.
    CANCER RESEARCH, 2022, 82 (12)
  • [9] WSD1227: A BRAIN PENETRABLE VEGFR2 INHIBITOR FOR THE TREATMENT OF PRIMARY AND METASTATIC BRAIN TUMORS
    Zhang, Jinqiang
    Zhong, Wei
    Mu, Zhihua
    Sun, Claire
    NEURO-ONCOLOGY, 2018, 20 : 30 - 30
  • [10] WSD1227: A novel, oral bioavailable, brain penetrable and reversible VEGFR inhibitor for the treatment of primary and metastatic brain tumors
    Zhang, Jinqiang
    Zhong, Wei
    Mu, Zhihua
    Sun, Claire
    CANCER RESEARCH, 2018, 78 (13)
12